These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24899282)

  • 1. Phage therapy gets revitalized.
    Reardon S
    Nature; 2014 Jun; 510(7503):15-6. PubMed ID: 24899282
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriophage therapy. Stalin's forgotten cure.
    Stone R
    Science; 2002 Oct; 298(5594):728-31. PubMed ID: 12399562
    [No Abstract]   [Full Text] [Related]  

  • 3. Phage cocktails and the future of phage therapy.
    Chan BK; Abedon ST; Loc-Carrillo C
    Future Microbiol; 2013 Jun; 8(6):769-83. PubMed ID: 23701332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of the Eliava Institute in bacteriophage therapy.
    Kutateladze M
    Virol Sin; 2015 Feb; 30(1):80-1. PubMed ID: 25662889
    [No Abstract]   [Full Text] [Related]  

  • 5. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophages as anti-infective agents: recent developments and regulatory challenges.
    Gilmore BF
    Expert Rev Anti Infect Ther; 2012 May; 10(5):533-5. PubMed ID: 22702317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: phage therapy: a modern tool to control bacterial infections.
    Qadir MI
    Pak J Pharm Sci; 2015 Jan; 28(1):265-70. PubMed ID: 25553704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage approved in food, why not as a therapeutic?
    Sarhan WA; Azzazy HM
    Expert Rev Anti Infect Ther; 2015 Jan; 13(1):91-101. PubMed ID: 25488141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial bioagents based on principles of bacteriophage biology: an overview.
    Knoll BM; Mylonakis E
    Clin Infect Dis; 2014 Feb; 58(4):528-34. PubMed ID: 24270166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respirable bacteriophages for the treatment of bacterial lung infections.
    Hoe S; Semler DD; Goudie AD; Lynch KH; Matinkhoo S; Finlay WH; Dennis JJ; Vehring R
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):317-35. PubMed ID: 23597003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bacteriophage journey at the European Medicines Agency.
    Debarbieux L; Pirnay JP; Verbeken G; De Vos D; Merabishvili M; Huys I; Patey O; Schoonjans D; Vaneechoutte M; Zizi M; Rohde C
    FEMS Microbiol Lett; 2016 Jan; 363(2):fnv225. PubMed ID: 26656541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage therapy: quo vadis?
    Brüssow H
    Clin Infect Dis; 2014 Feb; 58(4):535-6. PubMed ID: 24270168
    [No Abstract]   [Full Text] [Related]  

  • 13. The next generation of bacteriophage therapy.
    Lu TK; Koeris MS
    Curr Opin Microbiol; 2011 Oct; 14(5):524-31. PubMed ID: 21868281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.
    Chanishvili N
    Adv Virus Res; 2012; 83():3-40. PubMed ID: 22748807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European regulatory conundrum of phage therapy.
    Verbeken G; De Vos D; Vaneechoutte M; Merabishvili M; Zizi M; Pirnay JP
    Future Microbiol; 2007 Oct; 2(5):485-91. PubMed ID: 17927471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felix d'Herelle and our microbial future.
    Keen EC
    Future Microbiol; 2012 Dec; 7(12):1337-9. PubMed ID: 23231482
    [No Abstract]   [Full Text] [Related]  

  • 17. Profile of Paul E. Turner.
    Viegas J
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):18906-18908. PubMed ID: 32747551
    [No Abstract]   [Full Text] [Related]  

  • 18. Programming Bacteriophages by Swapping Their Specificity Determinants.
    Goren MG; Yosef I; Qimron U
    Trends Microbiol; 2015 Dec; 23(12):744-746. PubMed ID: 26526502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational models of populations of bacteria and lytic phage.
    Krysiak-Baltyn K; Martin GJ; Stickland AD; Scales PJ; Gras SL
    Crit Rev Microbiol; 2016 Nov; 42(6):942-68. PubMed ID: 26828960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
    Burrowes B; Harper DR; Anderson J; McConville M; Enright MC
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):775-85. PubMed ID: 21905786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.